$17.97
-0.19[-1.05%]
Last update: 12:43PM Get Real Time Here
Radius Recycling
(NASDAQ:RDUS)Latest News for Radius Recycling Stock (NASDAQ:RDUS)
Radius Recycling Stock (NASDAQ: RDUS)
Categories: All
Thursday, April 04, 2024
- Radius Recycling Reports Q2 Results; American Battery Awarded Another $40.5 Million; Nexa Prices $600 Million Offering And More: Thursday's Top Mining StoriesAustin DeNoce - Apr 4, 2024, 5:01PM
- Why Radius Recycling Shares Are Trading Lower TodayLekha Gupta - Apr 4, 2024, 12:25PM
- Schnitzer Steel Q2 Adj $(1.04) Beats $(1.09) Estimate, Sales $621.06M Miss $626.15M EstimateBenzinga Newsdesk - Apr 4, 2024, 8:08AM
- Earnings Scheduled For April 4, 2024Benzinga Insights - Apr 4, 2024, 5:18AM
Friday, March 15, 2024
Thursday, March 14, 2024
- Radius Recycling Anticipates Q2 Adjusted EPS From Continuing Operations Of $(1.05)-$(1.10), Est $(0.38)Benzinga Newsdesk - Mar 14, 2024, 4:46PM
- Radius Recycling Reports Preliminary Q2 Results, Says Current Market Conditions Remain Challenging; Increases Cost Reduction TargetBenzinga Newsdesk - Mar 14, 2024, 4:42PM
Thursday, January 04, 2024
- Foremost Lithium Receives Grant For Zoro Project; Radius Recycling's Quarterly Loss; US Gold Corp At 2024 Future Minerals ForumAustin DeNoce - Jan 4, 2024, 4:23PM
- Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Jan 4, 2024, 1:37PM
- Schnitzer Steel's Adjusted Loss Widens, But Still Outperforms Analyst ExpectationsAkanksha Bakshi - Jan 4, 2024, 11:15AM
- Schnitzer Steel shares are trading lower after the company reported Q1 financial results.Benzinga Newsdesk - Jan 4, 2024, 11:02AM
- Schnitzer Steel Q1 Adj EPS $(0.64) Beats $(0.70) Estimate, Sales $672.90M Beat $643.35M EstimateBenzinga Newsdesk - Jan 4, 2024, 8:02AM
- Earnings Scheduled For January 4, 2024Benzinga Insights - Jan 4, 2024, 7:59AM
Wednesday, January 03, 2024
Thursday, December 14, 2023
Wednesday, November 08, 2023
Wednesday, October 25, 2023
- General Dynamics, Microsoft, Waste Management And Other Big Stocks Moving Higher On WednesdayLisa Levin - Oct 25, 2023, 11:29AM
- Schnitzer Steel Q4 Adj EPS $0.47 Beats $0.31 Estimate, Sales $718.00M Miss $721.30M EstimateBenzinga Newsdesk - Oct 25, 2023, 8:02AM
- Earnings Scheduled For October 25, 2023Benzinga Insights - Oct 25, 2023, 7:32AM
Thursday, September 14, 2023
Monday, September 11, 2023
Thursday, August 11, 2022
- Recap Of Thursday's Biotech Catalysts - End Of the Day SummaryRagothaman Srinivasan - Aug 11, 2022, 6:07PM
- FDA Accepts Menarini Group and Radius Health's Filing Under Priority Review For Breast Cancer CandidateRagothaman Srinivasan - Aug 11, 2022, 9:06AM
- Menarini Group's Elacestrant Granted Priority Review By The U.S. FDA For Patients With ER+/HER2- Advanced Or Metastatic Breast CancerBenzinga Newsdesk - Aug 11, 2022, 6:48AM
Thursday, July 07, 2022
Tuesday, June 28, 2022
Friday, June 24, 2022
- 4 Analysts Have This to Say About Radius HealthBenzinga Insights - Jun 24, 2022, 8:41AM
- Velan-Repertoire Comments On Proposed Sale Of Radius Health To Gurnet Point Capital And Patient Square CapitalBenzinga Newsdesk - Jun 24, 2022, 8:32AM
- SVB Leerink Maintains Market Perform on Radius Health, Raises Price Target to $10Benzinga Newsdesk - Jun 24, 2022, 6:22AM
- Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From YesterdayLisa Levin - Jun 24, 2022, 5:35AM
Thursday, June 23, 2022
- Bone Health Focused Radius Health Goes Private In $890M DealVandana Singh - Jun 23, 2022, 12:08PM
- The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows PromiseVandana Singh - Jun 23, 2022, 10:31AM
- Radius Health shares are trading higher after the company announced an agreement to be acquire by Gurnet Point Capital and Patient Square Capital in a transaction valued at approximately $890 million.Bill Haddad - Jun 23, 2022, 9:32AM
- Radius Health Announces Agreement To Be Acquired By Gurnet Point Capital And Patient Square Capitall Says Potential Share Value Of $11, Including $10 Cash Paid At Closing And Potential $1 CVR; Total Transaction Worth ~$890MBenzinga Newsdesk - Jun 23, 2022, 9:16AM
Wednesday, June 22, 2022
Friday, June 17, 2022
Thursday, June 16, 2022
Wednesday, June 08, 2022
- Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022Benzinga Insights - Jun 8, 2022, 10:03AM
- B of A Securities Upgrades Radius Health to Neutral, Announces $8 Price TargetBenzinga Newsdesk - Jun 8, 2022, 8:59AM
- Radius Health Expands Non-US Market Footprint For TYMLOSBenzinga Newsdesk - Jun 8, 2022, 8:04AM
Monday, June 06, 2022
Wednesday, June 01, 2022
Tuesday, May 31, 2022
Tuesday, May 24, 2022
- Watching Radius Pharma Shares Following National Institutes Of Health ClinicalTrials.gov Study Record Detail 'A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome'Benzinga Newsdesk - May 24, 2022, 10:44AM
- Goldman Sachs Maintains Neutral on Radius Health, Lowers Price Target to $8Benzinga Newsdesk - May 24, 2022, 10:19AM